Levit Alex C. 4
4 · Context Therapeutics Inc. · Filed Feb 14, 2025
Insider Transaction Report
Form 4
Levit Alex C.
Chief Legal Officer, Corp. Sec
Transactions
- Award
Stock Option (right to buy)
2025-02-13+349,900→ 349,900 totalExercise: $0.81Exp: 2035-02-12→ Common Stock (349,900 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable over a four-year period. Twenty-five percent (25%) of the option vests and becomes exercisable on February 13, 2026, and the balance vests in equal monthly installments over the remaining three years of the four-year period, subject to continued service with the Issuer.